Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga December 28, 2015 at 08:28 AM EST Chimerix Inc (NASDAQ: CMRX) shares dipped 74.70 percent to $9.00 following Phase 3 trial failure. Chimerix announced in a press ... Read More >> Related Stocks: Baidu.com SP ADR Chimerix Inc ConocoPhillips Devon Energy Marathon Oil